Search results
Found 9297 matches for
The Epidemiology Department of MORU and National Malaria Control Programme, Cambodia (CNM) have begun to implement a study to assess the efficacy of prophylaxis with artemether-lumefantrine (PAL) against forest malaria in Siem Pang District, north-eastern Cambodia bordering Laos.
©
MORU 2020.
OTN 2024 pre-meeting workshops
Additional information about the OTN 2024 pre-meeting workshops
Medical Quality Product Report - COVID-19 issues Issue 15. Data from January, February & March 2022
The document has been produced by the Medicine Quality Research Group, Centre of Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford Part A: COVID-19 vaccines Part B: Other COVID-19 related medical products: Diagnostics Personal Protective Equipment Sanitisers & disinfectants Medicines Ventilation & oxygenation equipment and consumables
Medical Product Quality Report_Covid-19_Issue15_January-March2022_V1.1.pdf (1 MB)
COPCOV Statistical Analysis Plan
COPCOV Statistical Analysis Plan. This document is not entirely accessible, please contact us at adminassistants@tropmedres.ac if you have problems reading the PDF
COPCOV protocol
COPCOV protocol. This PDF is not entirely accessible, please contact us at adminassistants@tropmedres.ac is you have problems reading the PDF
COPCOV global protocol version 6.0 dated 13 Jan 2021-CLEAN.pdf (536 KB)
COPCOV Trial Position Statement
Following WHO recommendations against the use of hydroxychloroquine in the prevention of COVID-19, including its use in controlled trials, we are reviewing the guideline and the available evidence. We are concerned that this judgement from the authors of the guideline is scientifically unsound. Contact us at adminassistants@tropmedres.ac is you have problems reading the PDF
Medical Product Quality Report_Covid-19_Issue 14_October-December 2021_V2.pdf
Medical Product Quality Report Issue 17, October to December 2021.
Medical Product Quality Report_Covid-19_Issue 14_October-December 2021_V2.pdf (1 MB)
Medical Product Quality Report_Covid-19 Issues_Issue 12_June-July 2021_V1_MAIN TEXT excl annex D.pdf
Medical Quality Report - Issue 12 - June to July 2021 - main text excluding annex
Medical Product Quality Report_Covid-19 Issues_Issue 12_June-July 2021_V1_ANNEX D.pdf
Medical Quality Report - Issue 12 - June to July 2021 - Annex
Medical Product Quality Report_Covid-19 Issues_Issue 12_June-July 2021_V1_ANNEX D.pdf (1 MB)